Marshall Wace’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-117,744
Closed -$1.98M 3227
2026
Q1
$1.98M Buy
+117,744
New +$2.11M ﹤0.01% 1795
2025
Q1
Sell
-11,123
Closed -$193K 2680
2024
Q4
$193K Sell
11,123
-10,188
-48% -$197K ﹤0.01% 2363
2024
Q3
$395K Sell
21,311
-59,741
-74% -$1.2M ﹤0.01% 2010
2024
Q2
$1.64M Sell
81,052
-41,819
-34% -$740K ﹤0.01% 1457
2024
Q1
$2.1M Buy
122,871
+104,510
+569% +$1.64M ﹤0.01% 1344
2023
Q4
$324K Buy
+18,361
New +$370K ﹤0.01% 1863
2023
Q2
Sell
-19,970
Closed -$440K 2520
2023
Q1
$440K Buy
+19,970
New +$467K ﹤0.01% 2152
2022
Q4
Sell
-124,469
Closed -$1.68M 2980
2022
Q3
$1.68M Buy
124,469
+38,029
+44% +$641K ﹤0.01% 2125
2022
Q2
$1.71M Buy
+86,440
New +$2.3M ﹤0.01% 2101
2022
Q1
Sell
-835,491
Closed -$18.6M 3415
2021
Q4
$18.6M Buy
835,491
+662,216
+382% +$17.3M 0.03% 518
2021
Q3
$4.81M Buy
+173,275
New +$5.27M 0.02% 965
2019
Q2
Sell
-433
Closed -$30K 1413
2019
Q1
$30K Buy
+433
New +$29K ﹤0.01% 1594
2017
Q1
Sell
-8,065
Closed -$968K 374
2016
Q4
$968K Sell
8,065
-62,437
-89% -$6.91M 0.01% 757
2016
Q3
$7.92M Sell
70,502
-136,875
-66% -$15.8M 0.06% 322
2016
Q2
$25.7M Buy
207,377
+103,785
+100% +$12.5M 0.22% 117
2016
Q1
$11.6M Buy
+103,592
New +$10.8M 0.11% 190

Other funds holding CLB

Marshall Wace's CLB Position: Q2 2026 in Review

Marshall Wace sold out of Core Laboratories (CLB) in Q2 2026, closing a stake of 117,744 shares — an estimated $1.98M sold.

Marshall Wace first reported a position in CLB in Q1 2016 and held it in 16 quarters. The position peaked at $25.7M in Q2 2016. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Marshall Wace reported no remaining Core Laboratories position as of Q2 2026 after selling out during the quarter.
  • Marshall Wace sold 117,744 Core Laboratories shares in Q2 2026, an estimated $1.98M.
  • Marshall Wace first reported a position in Core Laboratories in Q1 2016 and held it in 16 quarters.
  • Marshall Wace's Core Laboratories position peaked at $25.7M in Q2 2016.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.